Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Ian Peers"'
Autor:
Kenny Kwok-Hei Yu, Jessica T Taylor, Omar N Pathmanaban, Amir Saam Youshani, Deniz Beyit, Joanna Dutko-Gwozdz, Roderick Benson, Gareth Griffiths, Ian Peers, Peter Cueppens, Brian A Telfer, Kaye J Williams, Catherine McBain, Ian D Kamaly-Asl, Brian W Bigger
Publikováno v:
PLoS ONE, Vol 13, Iss 3, p e0193694 (2018)
Glioblastoma (GBM) is the most common primary brain malignancy in adults, yet survival outcomes remain poor. First line treatment is well established, however disease invariably recurs and improving prognosis is challenging. With the aim of personali
Externí odkaz:
https://doaj.org/article/c0919e2e2f8a4abbb588898382f3d76c
Publikováno v:
Statistics in Medicine. 35:4909-4923
Potential predictive biomarkers are often measured on a continuous scale, but in practice, a threshold value to divide the patient population into biomarker 'positive' and 'negative' is desirable. Early phase clinical trials are increasingly using bi
Autor:
Joanna Dutko-Gwozdz, Omar N. Pathmanaban, Peter Cueppens, Kenny Yu, Brian A. Telfer, Gareth Griffiths, Ian Peers, Roderick Benson, Kaye J. Williams, Brian W. Bigger, Deniz Beyit, Catherine McBain, Ian Kamaly-Asl, Amir Saam Youshani, Jessica T. Taylor
Publikováno v:
PLoS ONE
Yu, K K H, Taylor, J T, Pathmanaban, O N, Youshani, A S, Beyit, D, Dutko-Gwozdz, J, Benson, R, Griffiths, G, Peers, I, Cueppens, P, Telfer, B A, Williams, K J, McBain, C, Kamaly-Asl, I D & Bigger, B W 2018, ' High content screening of patient-derived cell lines highlights the potential of non-standard chemotherapeutic agents for the treatment of glioblastoma ', PLoS ONE, vol. 13, no. 3, e0193694 . https://doi.org/10.1371/journal.pone.0193694
PLoS ONE, Vol 13, Iss 3, p e0193694 (2018)
Yu, K K H, Taylor, J T, Pathmanaban, O N, Youshani, A S, Beyit, D, Dutko-Gwozdz, J, Benson, R, Griffiths, G, Peers, I, Cueppens, P, Telfer, B A, Williams, K J, McBain, C, Kamaly-Asl, I D & Bigger, B W 2018, ' High content screening of patient-derived cell lines highlights the potential of non-standard chemotherapeutic agents for the treatment of glioblastoma ', PLoS ONE, vol. 13, no. 3, e0193694 . https://doi.org/10.1371/journal.pone.0193694
PLoS ONE, Vol 13, Iss 3, p e0193694 (2018)
Background Glioblastoma (GBM) is the most common primary brain malignancy in adults, yet survival outcomes remain poor. First line treatment is well established, however disease invariably recurs and improving prognosis is challenging. With the aim o
Autor:
Jessica Taylor, Kenny Yu, Omar Pathmanaban, Deniz Beyit, Joanna Dutko-Gwozdz, Rod Benson, Gareth Griffiths, Catherine McBain, Ian Peers, Peter Ceuppens, Ian Kamaly-asl, Brian Bigger
Publikováno v:
Neuro-Oncology. 20:i5-i6
Glioblastoma Multiforme (GBM) is the most common primary brain tumour in adults, yet survival outcomes remain poor. First line treatment is well established but with disease recurrence almost inevitable, improving prognosis is challenging. With the a
This book serves as a reference text for regulatory, industry and academic statisticians and also a handy manual for entry level Statisticians. Additionally it aims to stimulate academic interest in the field of Nonclinical Statistics and promote thi
Autor:
Marie C. South, Ian Peers
Publikováno v:
Nonclinical Statistics for Pharmaceutical and Biotechnology Industries ISBN: 9783319235578
This chapter provides an overview of the nonclinical drug safety testing process, and the statistical challenges associated with work in this area. Whilst other chapters in this book focus on specific types of designs and analyses which you may encou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a56e622010507a359af483c74f523f7e
https://doi.org/10.1007/978-3-319-23558-5_9
https://doi.org/10.1007/978-3-319-23558-5_9
Autor:
Marie C. South, Hsiao-kun Tu, Masahiro Tsuboi, Ian Peers, Takeshi Kawamura, Fredrik Nyberg, Toshihide Nishimura, Hideo Kunito, Chris Harbron, Shingo Akimoto, Atsushi Ogiwara, Harubumi Kato, Nakata K, Yutaka Kyono, Yutaka Nishiwaki, Mitsuhiro Kanazawa, Tim Higenbottam, Takao Kawakami, Masahiro Fukuoka, György Marko-Varga, Hisae Anyoji, Shuji Hada, Kazuto Nishio, Kiyonaga Fujii, Takashi Hirano, Haiyi Jiang, Shoji Kudoh
Publikováno v:
Journal of Proteome Research. 6:2925-2935
Personalized medicine allows the selection of treatments best suited to an individual patient and disease phenotype. To implement personalized medicine, effective tests predictive of response to treatment or susceptibility to adverse events are neede
Publikováno v:
Statistics in medicine
Potential predictive biomarkers are often measured on a continuous scale, but in practice, a threshold value to divide the patient population into biomarker 'positive' and 'negative' is desirable. Early phase clinical trials are increasingly using bi
Autor:
Sally A. Price, Rob Riley, Mike Dymond, Alison Holt, Rosanna Marsella, Ian Peers, Jaimini Reens, Malbinder Fagura, Clare Murray, Matt Devalaraja, Adam Hargreaves, Kim Ahrens
Publikováno v:
The Journal of investigative dermatology. 136(3)
Atopic dermatitis (AD) is an inflammatory skin disease characterized by infiltration of skin homing lymphocytes into the dermis. Most of these lymphocytes express the chemokine receptor CCR4, and the frequency of blood CCR4(+) lymphocytes correlates
Autor:
Deniz Beyit, Joanna Dutko-Gwozdz, Catherine McBain, Omar N. Pathmanaban, Kenny Yu, Ian Peers, Ian Kamaly-Asl, Jessica T. Taylor, Kaye J. Williams, Brian W. Bigger, Rod Benson, Peter Ceuppens, Brian A. Telfer, Gareth Griffiths
Publikováno v:
Neuro-Oncology. 19:vi85-vi85